Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland.

Tomonaga, Yuki; de Nijs, Koen; Bucher, Heiner C; de Koning, Harry; Ten Haaf, Kevin

Tomonaga, Yuki; de Nijs, Koen; Bucher, Heiner C; de Koning, Harry; Ten Haaf, Kevin.

Tomonaga Y; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
de Nijs K; Department of Public Health, Erasmus MC: University Medical Center Rotterdam, Rotterdam, The Netherlands.
Bucher HC; Division of Clinical Epidemiology, Department of Clinical Research University Hospital Basel and University of Basel, Basel, Switzerland.
de Koning H; Department of Public Health, Erasmus MC: University Medical Center Rotterdam, Rotterdam, The Netherlands.
Ten Haaf K; Department of Public Health, Erasmus MC: University Medical Center Rotterdam, Rotterdam, The Netherlands.

Int J Cancer ; 154(4): 636-647, 2024 Feb 15.

Article en En | MEDLINE | ID: mdl-37792671

Asunto(s)

Neoplasias Pulmonares; Humanos; Análisis Costo-Beneficio; Suiza/epidemiología; Neoplasias Pulmonares/diagnóstico por imagen; Neoplasias Pulmonares/epidemiología; Detección Precoz del Cáncer/métodos; Tomografía Computarizada por Rayos X/métodos; Tamizaje Masivo

Palabras clave

cost-effectiveness; low-dose computed tomography; lung cancer; risk-stratified; screening

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google